Condition
Cardiomyopathy, Congestive
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04623528CompletedPrimary
Characterization of the Liver Parenchyma Using Parametric T1 and T2 Magnetic Resonance Relaxometry
NCT03464981Completed
Observational Hemodynamic Monitoring During LVAD Implantation Among Individuals With Advanced Heart Failure
NCT00005201Completed
Idiopathic Dilated Cardiomyopathy
NCT00005156Completed
Mortality Surveillance of MRFIT Screenees
NCT00046618CompletedPrimary
Mapping Novel Disease Genes for Dilated Cardiomyopathy
Showing all 5 trials